Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca PLC    AZN   GB0009895292


SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Oil prices post weekly gain ahead of OPEC+ meeting

11/27/2020 | 02:53pm EST
FILE PHOTO: The sun sets behind a crude oil pump jack on a drill pad in the Permian Basin in Loving County

NEW YORK (Reuters) - Oil prices were mixed on Friday but posted a fourth straight week of gains ahead of an OPEC+ meeting early next week.

Brent crude January futures rose 38 cents to settle at $48.18 a barrel, while the more active February contract gained 46 cents to $48.25.

U.S. West Texas Intermediate (WTI) crude futures fell 18 cents to settle at $45.53 a barrel.

Brent rose 7.2% over the week, while WTI gained 8% for the week. Encouraging news on potential COVID-19 vaccines from AstraZeneca and others have lifted the markets. However, questions have been raised over AstraZeneca's "vaccine for the world," with several scientists sounding caution over the trial results.

"While a successful vaccine rollout should break the link between infection and mobility, even then global oil demand will likely only reach its pre-pandemic run rate by mid-2022," JP Morgan said.

The Organization of the Petroleum Exporting Countries (OPEC) and allies including Russia are leaning towards delaying next year's planned increase in oil output, said three sources close to the OPEC+ group.

OPEC+ was planning to raise output by 2 million barrels per day (bpd) in January - about 2% of global consumption - after record supply cuts this year. OPEC+ ministers are due to meet from Monday.

"The market expects prices to see a limited increase if OPEC+ indeed does what is expected and changes its planned route, postponing a planned supply increase from January," said Bjornar Tonhaugen, Rystad Energy's head of oil markets

A panel of OPEC+ will hold informal online talks on Sunday - a day later than scheduled, a source with the knowledge of the matter told Reuters.

Rising Libyan output is also contributing to concerns about oversupply in the market.

The OPEC member, which is exempt from the oil cuts, has added more than 1.1 million bpd of output since early September.

(Reporting by Stephanie Kelly in New York; additional reporting by Ahmad Ghaddar in London and Aaron Sheldrick in Tokyo; Editing by Marguerita Choy and Louise Heavens)

By Stephanie Kelly

© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC -0.01% 7650 Delayed Quote.4.45%
LONDON BRENT OIL -1.16% 55.48 Delayed Quote.8.20%
US DOLLAR / RUSSIAN ROUBLE (USD/RUB) -0.12% 73.841 Delayed Quote.-0.40%
WTI -0.96% 52.477 Delayed Quote.10.35%
All news about ASTRAZENECA PLC
12:01aASTRAZENECA : Brazil awaits vaccine cargo from India amid supply concerns
01/21ASTRAZENECA : Fire Claims Five at AstraZeneca's COVID-19 Vaccine Maker Serum Ins..
01/21Swiss Health Minister Wants Cantons to Roll Out COVID-19 Vaccinations Despite..
01/21EXCLUSIVE : India to begin commercial vaccine exports with shipments to Brazil, ..
01/21ASTRAZENECA : Brazil announces incoming vaccine cargo amid supply concerns
01/21Pfizer-BioNTech agree to supply WHO co-led COVID-19 vaccine scheme -sources
01/21Pfizer cuts vaccine deliveries by as much as half to some EU countries
01/21European ADRs Edge Lower in Thursday Trading
01/21South Africa to pay $5.25 a dose for AstraZeneca vaccine from India's SII
01/21COVID-19 vaccine production unaffected by deadly Indian fire, company says
More news
Financials (USD)
Sales 2020 26 407 M - -
Net income 2020 2 973 M - -
Net Debt 2020 13 207 M - -
P/E ratio 2020 41,9x
Yield 2020 2,68%
Capitalization 138 B 138 B -
EV / Sales 2020 5,72x
EV / Sales 2021 4,96x
Nbr of Employees 70 600
Free-Float 95,7%
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 25
Average target price 126,41 $
Last Close Price 105,02 $
Spread / Highest target 48,6%
Spread / Average Target 20,4%
Spread / Lowest Target -14,1%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Pam P. Cheng Executive VP-Operations & Information Technology
Marc Pierre Jean Dunoyer Chief Financial Officer & Executive Director
Menelas N. Pangalos EVP-Biopharmaceuticals Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON2.76%427 472
ROCHE HOLDING AG3.56%308 129
NOVARTIS AG2.82%219 666
MERCK & CO., INC.0.81%208 627
PFIZER INC.-0.90%202 881